Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob

Toru Suzuki1, Junko Tsuzuku, Akiyo Hayashi

  • 1Department of Cancer Biology, Division of Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Tokyo 108-8639, Japan.

Abstract

Insights

The DNA replication kinase Cdc7 prevents cell death in DNA-damaged cells. Cdc7 stabilizes the Tob protein by inhibiting its degradation, thus promoting cell survival during DNA repair.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Genetics

Background:

  • Preventing unnecessary cell death is crucial for DNA repair in damaged cells.
  • Understanding how cells escape apoptosis during DNA repair is vital for maintaining genomic integrity.
  • Cells balance proliferation arrest and apoptosis to manage DNA damage.

Purpose of the Study:

  • To investigate the role of Cdc7 in preventing cell death in DNA-damaged cells.
  • To elucidate the mechanism by which DNA-damaged cells maintain viability.
  • To identify signaling pathways that promote cell survival post-DNA damage.

Main Methods:

  • Investigated the effect of Cdc7 on Tob protein levels and degradation.
  • Examined the interaction between Cdc7 and Tob.
  • Analyzed the role of Cul4-DDB1(Cdt2) complex in Tob ubiquitination and degradation.
  • Assessed cell viability in response to DNA damage in the presence and absence of Cdc7.

Main Results:

  • Cdc7 inhibits the Cul4-DDB1(Cdt2)-dependent degradation of Tob.
  • Cdc7 phosphorylates and interacts with Tob, stabilizing it.
  • Cells lacking Cdc7 undergo apoptosis after mild DNA damage due to Tob degradation.
  • Mild DNA damage leads to increased Tob levels via transcriptional and stabilization mechanisms, inhibiting apoptosis.

Conclusions:

  • Cdc7 is a key pro-survival kinase that maintains the viability of DNA-damaged cells.
  • Cdc7 promotes cell survival by stabilizing Tob and counteracting the Tob degradation system.
  • The Cdc7-Tob pathway represents an essential pro-survival signaling mechanism in response to DNA damage.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.